AI-powered tools are enhancing precision, efficiency, and decision-making in biopharmaceutical development. Recently, Jared ...

The Global Biologics CDMO Market is expected to witness a growth rate of 14-16% in the next five years. Growing ...

US biotech company SparX Biopharmaceutical has signed a research agreement with Mitsubishi Tanabe Pharma America aimed at ...

Held April 2, 2025; New Drug Application Submission Targeted for Mid-2025 Non-Dilutive Funding to Accelerate Development of ...

He will discuss how Kernel, a software design tool that powers Asimov’s CHO Edge system, can accelerate timelines and improve titers for cell line and process development. The webinar will cover ...

These insights help researchers fine-tune biopharmaceutical processes, reducing development timelines and increasing the likelihood of regulatory approval. Regulatory compliance is another area where ...

ProBioGen inks agreement with Polpharma Biologics to provide high-performance cell line development services: Gdansk, Poland Friday, May 9, 2025, 17:00 Hrs [IST] ProBioGen, a Berl ...

Phio's one-on-one meetings with investors will take place on Wednesday and Thursday, May 21-22, 2025 and can be accessed here: REGISTRATION LINK FOR PRESENTATION OR ONE-ON-ONE MEETINGS: www.sidoti.com ...

Developing orphan drugs involves navigating intricate regulatory landscapes, financial risks, and limited clinical data. To ...

The Company is currently conducting two additional SPC-15 studies: an IND-enabling GLP (Good Laboratory Practice)-compliant ...